The Transnational Governance of Synthetic Biology: Scientific uncertainty, cross-borderness and the ‘art’ of governance. For the Royal Society Science Policy Centre (UK).

Synthetic biology is a new field of research that aims to 'make biology easier to engineer'. Some claim

that it could revolutionise biotechnology to deliver applications for the energy, medical and

agricultural sectors. However there are concerns about potential environmental and health risks, the

creation of monopolies dominated by large multinational corporations, and the ethics of creating

artificial life. How should synthetic biology be best governed to maximise benefits and minimise

risks? In the last seven years, some 40 reports (in the English language alone) have addressed the

social, ethical and legal issues raised by synthetic biology. This Working Paper, based on an extensive

literature review and fieldwork in the UK, China and Japan, BIOS proposes a radical new approach to

these issues.